[Current possibilities and perspectives of the combined treatment of patients with severe bronchopulmonary diseases].
Complex treatment with ceftriaxone (or ceftazidime) and intravenous immunoglobulin G (Biaven V. I.) was performed at 21 patients with severe pneumonia and tracheobronchitis complicated by immunedeficient status (myasthenia, diabetes mellitus etc). The results of the treatment proves strong tendency to normalization of the immune system (ceruloplasmin level, CIC, catalase, immunoglobulins) along with clinical signs regression.
Sokolova
V I
VI
Russian Medical Academy of Post-Graduated Education, Moscow.
Shenderovich
V A
VA
Orlov
V A
VA
Elagina
L V
LV
D000368:Aged; D000890:Anti-Infective Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001991:Bronchitis / Q000276:immunology / Q000382:microbiology / Q000628:therapy*; D002442:Ceftazidime / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002443:Ceftriaxone / Q000493:pharmacokinetics / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D003428:Cross Infection / Q000276:immunology / Q000382:microbiology / Q000628:therapy; D004352:Drug Resistance, Microbial; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage / Q000627:therapeutic use*; D007275:Injections, Intravenous; D008875:Middle Aged; D018410:Pneumonia, Bacterial / Q000276:immunology / Q000382:microbiology / Q000628:therapy*
D000890:Anti-Infective Agents; D007074:Immunoglobulin G; D002443:Ceftriaxone; D002442:Ceftazidime